U.S. Consumer Durables Stock News

Solaris Energy Infrastructure (SEI) delivered a jump in net profit margin to 6.7% from last year’s 4.5%, riding a powerful 185.3% annual earnings growth that leaves its five-year average of 51.1% behind. Forecasts point to revenue growing 22.1% per year and an earnings climb of 41.4% per year, both well ahead of the broader US market pace. In this context of robust profitability, investors have to weigh a below-fair-value share price of $53.71 versus a discounted cash flow estimate of...

SNDL (NasdaqCM:SNDL) narrowed its losses by an average of 16.4% per year over the last five years, with forecasts now calling for explosive 168.19% annual earnings growth and a move to profitability within three years. While revenue is anticipated to grow just 2.8% per year, lagging the US market’s 10.5% rate, shares have remained volatile in recent months and stability is still elusive. Investors are weighing this rapid progress on the earnings front and SNDL’s discounted Price-to-Sales...

Great Lakes Dredge & Dock (GLDD) delivered a standout earnings result, posting a 36.3% increase in earnings over the past year, well ahead of its five-year average growth of 4.1% per year. The company’s net profit margin improved to 9.7%, up from 8% previously. This signals stronger profitability and efficiency even as the stock trades at $12.77, a premium relative to one benchmark of fair value. With high-quality earnings and a steady track record of growing profit or revenue, GLDD’s results...

Vitesse Energy (VTS) reported a net profit margin of 8.4%, well below last year’s 19.8%, as the company’s most recent period saw negative earnings growth despite averaging 24.1% annual earnings growth over the past five years. Looking ahead, revenue is projected to grow at just 0.9% per year, lagging the wider US market’s 10.5% average, and earnings are expected to drop sharply by 68.5% per year over the next three years. With shrinking margins and a premium 38.6x price-to-earnings ratio, the...

Bogota Financial (BSBK) has turned the corner to profitability, reporting positive net profit margins after a period of persistent earnings pressure. Despite this recent improvement, the company’s earnings have slid by an average of 40.7% per year over the last five years. This underscores a challenging backdrop for long-term investors. The latest report highlights that earnings quality remains high, even as historical performance continues to weigh on sentiment. See our full analysis for...

AC Immune (ACIU) remains unprofitable, with its net profit margin still negative. The company has narrowed its losses by an average of 5.9% annually over the past five years. Looking ahead, earnings are forecast to jump 66.51% per year and consensus expects profitability within three years. Revenue is set to rise 55.6% per year, outpacing the broader US market's projected growth of 10.5%. Despite a higher price-to-book ratio of 4.2x compared to the US Biotech industry's 2.5x, ACIU shares are...

Sphere Entertainment (SPHR) remains in the red, with losses worsening by 26.3% per year over the past five years. Revenue is projected to rise at an annual rate of 6.3%, lagging the broader US market's expected 10.5% per year. The company’s net profit margin shows no signs of improvement. While Sphere Entertainment’s shares trade below estimated fair value and the Price-to-Sales ratio of 2.3x is attractive compared to peer averages, ongoing unprofitability and slower revenue growth will...

HealthStream (HSTM) reported net profit margins of 6.9%, ticking up from last year’s 6.8%. Earnings have grown at an average annual rate of 18% over the last five years, but most recent annual earnings growth was 5%, coming in below that longer-term pace. Revenue is forecast to rise 4.7% per year and earnings at 7.7%, both trailing expectations for the wider US market. Valuation metrics present a mixed picture with the share price trading below one fair value estimate and a P/E lower than its...

Emergent BioSolutions recently reported third-quarter 2025 results, with revenue of US$231.1 million and net income of US$51.2 million, and raised its full-year 2025 guidance for both revenue and net income. The company's stronger-than-expected performance was supported by growth in NARCAN nasal spray, new U.S. government and international contracts, and a completed share repurchase program. We'll now examine how the company's upgraded full-year outlook and growth in core product lines may...

Eve Holding (EVEX) shares recently moved lower, catching the attention of investors tracking broader trends in advanced air mobility. The drop comes as market participants weigh the company’s long-term growth prospects in comparison to recent volatility. See our latest analysis for Eve Holding. While Eve Holding’s share price has pulled back sharply in recent weeks, including a 33.6% slide over the last three months, the company still boasts a remarkable one-year total shareholder return of...

Safety Insurance Group (SAFT) posted a net profit margin of 7.1%, edging ahead of last year’s 6.8%, with EPS showing 16.7% growth for the year. This upbeat result comes despite a longer-term backdrop where average annual earnings have dropped 22.2% over five years. For investors, high-quality earnings, positive profitability trends, and an attractive dividend balance out concerns around continued long-term earnings declines and shares currently trading at $70.37, above fair value...

Tactile Systems Technology (TCMD) posted a net profit margin of 5.8%, edging above last year’s 5.4% and capping five years of earnings growing at a brisk 42.6% annual clip. Looking ahead, analysts expect earnings to climb a further 12.26% per year with revenue growth forecast at 8.9% per year, which is slower than the US market’s 10.5% projection. The setup combines an above-average valuation, a solid record of profitability, and margins that continue to climb. This sets the stage for...

Comstock Resources (CRK) turned profitable over the past five years, boasting average annual earnings growth of 8.6% and posting net profit margins finally in positive territory. Wall Street is sizing up this momentum, with forecasts calling for a massive 74.6% annual earnings growth, which easily outpaces the US market’s expected 16%. Revenue, meanwhile, is projected to rise at 9.8% per year, just a touch behind the US average of 10.5%. See our full analysis for Comstock Resources. Next, we...

RTX announced that its board declared a quarterly cash dividend of 68 cents per share, payable December 11, 2025, to shareholders of record as of November 21, 2025. Alongside this, RTX reported third-quarter adjusted EPS and revenue ahead of forecasts and raised its full-year guidance, reflecting broad-based demand in defense and commercial aerospace. We'll explore how RTX's raised guidance on the back of strong defense and aerospace demand may influence its investment outlook. This...

Rocket Companies recently reported its third-quarter 2025 results, showing revenue of US$1.61 billion compared to US$646.95 million a year earlier, but with a wider net loss of US$123.85 million versus US$22.01 million previously. Despite a substantial increase in revenue, Rocket's bottom line deteriorated, highlighting that higher sales have not yet translated into improved profitability for the company. We'll examine how Rocket's increase in revenue alongside a deepening net loss could...

SOPHiA GENETICS (NasdaqGS:SOPH) is forecast to post annual revenue growth of 17.91%, surpassing the broader US market's expected 10.5% rate. The company has not yet achieved profitability and losses have actually grown at 4% per year for the past five years, with its net profit margin still in negative territory. For investors, the critical narrative is clear: the top-line growth potential stands out, but persistent losses and questions around the path to profitability remain a defining...

Devon Energy (DVN) has recently seen its stock performance fluctuate, capturing the attention of investors interested in the energy sector’s ongoing shifts. The company’s recent returns over the past month and quarter illustrate this ongoing volatility. See our latest analysis for Devon Energy. Devon Energy’s 1-year total shareholder return is down nearly 15%, and momentum has been choppy despite occasional short-term gains. With shares currently at $32.55, the stock’s long-term run remains...

Calm Health’s new partnership with LifeStance Health Group (LFST) makes it easier for users of the Calm Health app to access higher-acuity mental health services, including therapy, psychiatry, and psychological testing. This collaboration is set to widen LifeStance’s reach in digital mental health care and could support increased patient volume and utilization of its clinical services. See our latest analysis for LifeStance Health Group. While LifeStance Health Group’s latest partnership...

Bath & Body Works recently appointed Maly Bernstein as Chief Commercial Officer and Samantha Charleston as Chief Human Resources Officer, effective November 12, 2025, in a move aimed at advancing its ongoing transformation plans. This leadership update brings seasoned expertise in digital and omnichannel retail, as well as large-scale organizational change, directly addressing some of the company’s key operational and market challenges. We’ll now explore how the addition of Bernstein’s...

Greenlight Capital Re (GLRE) remains unprofitable, but the company has narrowed its losses over the last five years at an annual rate of 25.2%. Despite the ongoing challenges to net profit margin, the stock is drawing investor attention thanks to a low Price-To-Sales Ratio of 0.6x versus a peer average of 4.9x and a trading price of $11.95, well below an estimated fair value of $20.06. With risk sentiment steady and no major negative headlines, the current results put the spotlight on...

Xometry (XMTR) remains unprofitable, with net losses rising at an annual rate of 2.3% over the past five years and no meaningful progress on profit margins. Despite persistent losses, revenue is forecast to increase by 14.8% per year, which would outpace the broader US market's 10.5% growth. Earnings are projected to jump 99% annually, with profitability expected within three years. Investors attracted to Xometry's rapid top-line growth and the promise of a turnaround must weigh this optimism...

Bowhead Specialty Holdings (BOW) posted an impressive set of headline numbers, with earnings forecast to grow at 23.5% per year, well above the US market average of 16%, and revenue projected to rise 19.3% annually compared to the broader market’s 10.5%. Net profit margin improved to 10.1% from last year’s 7.6%, signaling a clear strengthening in profitability. With earnings quality described as high and expectations set for robust growth, investors are likely to focus on the company's...

Bioventus (BVS) recently swung to profitability in the past year, despite an average earnings decline of 16.6% per year over the last five years. The bottom line was affected by a non-recurring loss of $17.3 million for the twelve months ending September 27, 2025. Although revenue is forecast to grow at 6.1% annually, this pace trails the broader US market's 10.5% average. Trading at $7.55, the stock sits well below its estimated fair value of $17.96 and also below analyst targets. Its high...

Ingredion (NYSE:INGR) reported a net profit margin of 9.1%, just above last year’s 9%. Over the past five years, the company has delivered robust annual earnings growth of 23.9%. Looking ahead, forecasts point to much slower annual increases of 1.8% for earnings and 2% for revenue, trailing the broader US market averages of 16% and 10.5% respectively. Investors may still find value here, as the stock’s price-to-earnings ratio of 10.5x comes in well below both the peer and industry averages,...